Daniel Peter McNicholas

Dr. Daniel Peter McNicholas

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2024 in Journal of Robotic Surgery
Verified
Journal Article
Open access
PDF file
DMDaniel Peter McNicholas
Daniel Peter McNicholas
OEOmar El-Taji
Omar El-Taji
ZSZain Siddiqui
Zain Siddiqui
VHVishwanath Hanchanale
Vishwanath Hanchanale
Cystectomy is the gold standard treatment for muscle invasive bladder cancer. Robotic cystectomy has become increasingly popular owing to quicker post- operative recovery, less blood loss and less post-operative pain. Urinary diversion is increasingly being performed with an intracorporeal technique. Uretero-enteric strictures (UES) cause significant morbidity for patients. UES for open cystectomy is 3–10%, but the range is much wider (0–25%) for robotic surgery. We aim to perform systematic review for studies comparing all 3 techniques, to assess for ureteric stricture rates. A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement (Page et al. in BMJ 29, 2021). PubMed, Scopus and Embase databases were searched for the period January 2003 to June 2023 inclusive for relevant publications.The primary outcome was to identify ureteric stricture rates for studies comparing open cystectomy and urinary diversion, robotic cystectomy with extracorporeal urinary diversion (ECUD) and robotic cystectomy with intracorporeal urinary diversion (ICUD). Three studies were identified and included 2185 patients in total. The open operation had the lowest stricture rate (9.6%), compared to ECUD (12.4%) and ICUD (15%). ICUD had the longest time to stricture (7.55 months), ECUD (4.85 months) and the open operation (4.75 months). Open operation had the shortest operating time. The Bricker anastomoses was the most popular technique. Open surgery has the lowest rates of UES compared to both robotic operations. There is a learning curve involved with performing robotic cystectomy and urinary diversion, this may need to be considered to decide whether the technique is comparable with open cystectomy UES rates. Further research, including Randomised Control Trials (RCT), needs to be undertaken to determine the best surgical option for patients to minimise risks of UES.

3 September 2024 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Open access
PDF file
DMDaniel Peter McNicholas
Daniel Peter McNicholas
ATAlexander Taylor
Alexander Taylor
ABAndrew D. Baird
Andrew D. Baird
Introduction: Male urethral stricture affects 100 in 100,000 men. These are investigated using uroflowmetry, retrograde urethrography and cystourethroscopy. Management is usually endoscopic with urethral dilation or direct visual internal urethrotomy, although they have high failure rates. It is now recommended that urethroplasty is performed earlier. In this study we have reviewed a single surgeons experience with urethroplasty and patient outcomes. Methods: We retrospectively reviewed a prospectively maintained database of all urethroplasty operations performed in our hospital over a 5 -year period. Results: Forty-five patients were identified, with a mean age of 46. The most common presenting symptom was poor flow (100%). Uroflowmetry was performed in 31 of 45 patients(69%). More patients had a urethrogram (58%) than flexible cystoscopy (38%). Most strictures were idiopathic (67%). Mean stricture length was 2.6 cm. 71% did not require any further intervention. Five patients required repeat surgery. Four required DVIU and one required a repeat urethroplasty. Discussion: The most popular techniques for urethroplasty in the UK are augmentation urethroplasty using a buccal mucosal graft and anastomotic urethroplasty, both of which we describe. There are variations in what is deemed as successful surgery. The most widely used definition is ‘the lack of need for any further operative intervention’. We have recently adopted Patient Reported Outcome Measures using a validated questionnaire to measure the patients perception of a successful outcome. Complex strictures have a higher incidence of complications. 42% of our cohort were complex and we describe results comparable to the published literature.

18 January 2024 in BJU International
Verified
Journal Article
Closed access
DMDaniel Peter McNicholas
Daniel Peter McNicholas
NPNigel J. Parr
Nigel J. Parr

8 August 2025 in Urologia Internationalis
Verified
Journal Article
Closed access
ZSZain Ahmed Siddiqui
Zain Ahmed Siddiqui
DMDaniel Peter McNicholas
Daniel Peter McNicholas
ASAdam Spacey
Adam Spacey
IPIan Pearce
Ian Pearce
VMVaibhav Modgil
Vaibhav Modgil
Introduction: Erectile dysfunction is a debilitating condition defined as the inability to achieve or maintain penile erection sufficient for satisfactory sexual activity. Obstructive sleep apnoea is a common sleep disorder resulting in episodes of intermittent hypoxia experienced by the patient. It has been hypothesized that a link between both conditions exists. This systematic review aims to evaluate the current literature and synthesize the evidence linking erectile dysfunction and obstructive sleep apnoea, the possible pathogenesis involved, and potential treatment options available. Methods: This is a mixed-method systematic review and narrative synthesis reporting qualitative and quantitative data. The databases MEDLINE, PubMed, and Embase were searched between January 2000 and January 2022. Results: Eighteen studies were included, comprising 5 randomized controlled trials, 11 prospective studies, and 2 cross-sectional studies. The literature has reported up to 82% prevalence of ED in patients with OSA. Studies investigating the role of CPAP in treating ED in this cohort of patients have shown results varying from no significant effect to complete resolution of ED. Conclusion: There does appear to be an association between the presence of OSA and ED. Further randomized controlled trials to evaluate the efficacy of CPAP on ED in patients with OSA need to be conducted. Until more robust evidence is available, CPAP is a safe treatment likely to improve symptoms in individuals with OSA. However, the degree to which it may affect ED symptoms is not yet clear, but what appears clear is that it does not negatively impact on erectile function and is most likely to offer some degree of improvement.

28 November 2025 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Open access
PDF file
DMDaniel Peter McNicholas
Daniel Peter McNicholas
EDEloise Dexter
Eloise Dexter
AHAlexander Hampson
Alexander Hampson
JEJonathan Evans
Jonathan Evans
SVSuresh Venugopal
Suresh Venugopal
Background: Percutaneous ablative procedures such as radiofrequency ablation (RFA) are recognised as safe and effective treatment for small renal masses. These techniques are routinely used for metastases of other cancers such as lung or colorectal cancer. Aims: We aim to assess the feasibillity and safety of these treatments for metastatic RCC. Methods: A systematic review of the literature was performed searching for primary papers reporting outcomes on percutaneous ablative procedures such as RFA or cryoablation for the treatment of metastases of RCC. The study is registered with PROSPERO and is conducted in line with PRISMA guidelines. Results: Seven studies were identified with a total of 752 patients undergoing 961 radiofrequency ablation sessions for 1423 metastases were included in this systematic review. Of the seven studies, 4 were single centre retrospective cohort studies, 2 were multi-centre retrospective cohort studies and 1 was monocentric prospective study. The mean age of patients in this study is 63.74 years and 34.4% were female. Mean follow up ranged from 10 to 61 months. Mean tumour size ranged from 12 to 79 mm. Overall Survival ranges from 50 to 100% from 5 years onwards post RFA. Overall we report a 30% risk of pneumothorax, 1.2% risk of non-pneumothorax complication and 0.1% risk of death per metastases treated. Conclusion: This is the first systematic review on this subject. We have shown that RFA can be safely used for metastatic RCC. It demonstrates acceptable oncological outcomes, comparable to surgical metastectomy.